Health care companies by P/B ratio
Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.
Kodiak Sciences leads the 128 health care companies ranked by P/B ratio, at 497, ahead of Mettler-Toledo International (440) and Travere Therapeutics (208). Figures as of 19 Nov 2026, 17:00 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 128
- First
- Kodiak Sciences497
- Median
- 5.4
- Combined market value
- CZK 199.38T
- Countries
- 14
- Not ranked
- 42no P/B ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/B ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Kodiak SciencesKOD · Health Care | 497 | CZK 141.7B | CZK 2,167.05 | 0.50% down | 399% up | ||
| 2 | Mettler-Toledo InternationalMTD · Health Care | 440 | CZK 761.4B | CZK 38,279.72 | 1.05% down | 24% up | ||
| 3 | Travere TherapeuticsTVTX · Health Care | 208 | CZK 104.9B | CZK 1,093.10 | 2.29% down | 45% up | ||
| 4 | Arrowhead PharmaceuticalsARWR · Health Care | 122 | CZK 136.3B | CZK 964.40 | 0.46% up | 13% up | ||
| 5 | Rhythm PharmaceuticalsRYTM · Health Care | 92.5 | CZK 181.2B | CZK 2,613.18 | 1.42% down | 18% up | ||
| 6 | Axsome TherapeuticsAXSM · Health Care | 66.8 | CZK 156.8B | CZK 2,981.81 | 0.07% down | 6% down | ||
| 7 | InsmedINSM · Health Care | 42.7 | CZK 691.4B | CZK 3,151.49 | 18.14% up | 40% down | ||
| 8 | Scholar Rock HoldingSRRK · Health Care | 36.4 | CZK 136.7B | CZK 1,120.38 | 4.82% up | 26% up | ||
| 9 | Medpace HoldingsMEDP · Health Care | 30.6 | CZK 399.3B | CZK 14,274.23 | 0.90% down | 10% up | ||
| 10 | Eli LillyLLY · Health Care | 30.1 | CZK 26.95T | CZK 30,254.58 | 1.74% down | 33% up | ||
| 11 | IDEXX LaboratoriesIDXX · Health Care | 29.1 | CZK 1.21T | CZK 15,393.38 | 1.03% down | 1% up | ||
| 12 | Adaptive BiotechnologiesADPT · Health Care | 26.7 | CZK 104.8B | CZK 647.53 | 2.18% up | 74% up | ||
| 13 | NateraNTRA · Health Care | 22.9 | CZK 959B | CZK 6,613.61 | 2.59% up | 28% up | ||
| 14 | GlaukosGKOS · Health Care | 19.3 | CZK 308.4B | CZK 5,208.99 | 0.36% up | 145% up | ||
| 15 | CencoraCOR · Health Care | 17.7 | CZK 1.45T | CZK 7,585.36 | 2.20% down | 4% down | ||
| 16 | AmgenAMGN · Health Care | 16.7 | CZK 5.32T | CZK 9,837.69 | 0.47% down | 32% up | ||
| 17 | TG TherapeuticsTGTX · Health Care | 16.2 | CZK 222.7B | CZK 1,473.43 | 0.08% up | 117% up | ||
| 18 | Gilead SciencesGILD · Health Care | 15.9 | CZK 4.62T | CZK 3,728.21 | 0.92% down | 35% up | ||
| 19 | Summit TherapeuticsSMMT · Health Care | 15.0 | CZK 188.8B | CZK 236.03 | 0.95% up | 36% down | ||
| 20 | Madrigal PharmaceuticalsMDGL · Health Care | 14.8 | CZK 207.2B | CZK 8,919.50 | 0.62% up | 27% down | ||
| 21 | Revolution MedicinesRVMD · Health Care | 14.6 | CZK 779.8B | CZK 3,605.30 | 1.31% up | 129% up | ||
| 22 | HeartflowHTFL · Health Care | 14.1 | CZK 89B | CZK 1,012.27 | 0.94% down | 66% up | ||
| 23 | Amneal PharmaceuticalsAMRX · Health Care | 14.0 | CZK 166.1B | CZK 476.74 | 2.15% down | 90% up | ||
| 24 | DexComDXCM · Health Care | 11.9 | CZK 669.8B | CZK 1,795.97 | 2.26% down | 41% up | ||
| 25 | ModernaMRNA · Health Care | 11.8 | CZK 1.79T | CZK 4,433.09 | 1.17% up | 780% up | ||
| 26 | Ionis PharmaceuticalsIONS · Health Care | 11.4 | CZK 99.9B | CZK 599.88 | 1.64% down | 63% down | ||
| 27 | Cogent BiosciencesCOGT · Health Care | 10.8 | CZK 108.7B | CZK 624.81 | 0.90% up | 20% down | ||
| 28 | Hims & Hers HealthHIMS · Health Care | 10.7 | CZK 84.9B | CZK 362.29 | 4.57% down | 49% down | ||
| 29 | Concentra Group Holdings ParentCON · Health Care | 10.3 | CZK 115.9B | CZK 922.09 | 1.21% down | 116% up | ||
| 30 | ImmunovantIMVT · Health Care | 10.3 | CZK 151.1B | CZK 730.03 | 1.16% down | 46% up | ||
| 31 | ZoetisZTS · Health Care | 10.2 | CZK 747B | CZK 1,838.39 | 3.52% down | 26% down | ||
| 32 | IlluminaILMN · Health Care | 10.1 | CZK 701.6B | CZK 4,640.51 | 0.77% down | 76% up | ||
| 33 | Spyre TherapeuticsSYRE · Health Care | 9.8 | CZK 209.1B | CZK 2,202.24 | 2.52% down | 332% up | ||
| 34 | 10x GenomicsTXG · Health Care | 9.4 | CZK 176B | CZK 1,338.04 | 5.29% up | 247% up | ||
| 35 | West Pharmaceutical ServicesWST · Health Care | 9.4 | CZK 617.5B | CZK 8,864.06 | 1.47% down | 57% up | ||
| 36 | Twist BioscienceTWST · Health Care | 9.1 | CZK 181.5B | CZK 2,662.50 | 2.77% up | 346% up | ||
| 37 | Intuitive SurgicalISRG · Health Care | 9.0 | CZK 3.21T | CZK 9,254.96 | 1.26% down | 24% down | ||
| 38 | ExelixisEXEL · Health Care | 8.8 | CZK 360.3B | CZK 1,476.77 | 2.88% down | 63% up | ||
| 39 | Caris Life SciencesCAI · Health Care | 8.7 | CZK 124.3B | CZK 433.32 | 0.21% down | 19% down | ||
| 40 | Corcept TherapeuticsCORT · Health Care | 8.6 | CZK 159B | CZK 1,452.94 | 3.75% down | 10% down | ||
| 41 | ChemedCHE · Health Care | 8.2 | CZK 156.8B | CZK 12,097.94 | 0.62% down | 27% up | ||
| 42 | PenumbraPEN · Health Care | 8.0 | CZK 280.8B | CZK 7,125.54 | 0.19% down | 15% up | ||
| 43 | Johnson & JohnsonJNJ · Health Care | 7.9 | CZK 14.34T | CZK 5,957.39 | 1.89% down | 34% up | ||
| 44 | Belite BioBLTE · Health Care | 7.9 | CZK 139.2B | CZK 3,426.71 | 1.50% down | 43% up | ||
| 45 | BillionToOneBLLN · Health Care | 7.6 | CZK 96.7B | CZK 2,024.99 | 0.66% down | 4% down | ||
| 46 | Protagonist TherapeuticsPTGX · Health Care | 7.6 | CZK 182.7B | CZK 2,799.33 | 1.14% down | 51% up | ||
| 47 | Merck & CoMRK · Health Care | 7.4 | CZK 7.37T | CZK 2,989.94 | 2.54% down | 45% up | ||
| 48 | CG OncologyCGON · Health Care | 7.3 | CZK 161.6B | CZK 1,809.00 | 1.55% up | 97% up | ||
| 49 | Praxis Precision MedicinesPRAX · Health Care | 7.0 | CZK 195B | CZK 6,975.12 | 2.64% up | 86% up | ||
| 50 | Agilent TechnologiesA · Health Care | 6.8 | CZK 1.12T | CZK 3,956.45 | 0.20% up | 22% up | ||
| 51 | VeradermicsMANE · Health Care | 6.6 | CZK 116.2B | CZK 2,754.13 | 0.94% down | 231% up | ||
| 52 | Krystal BiotechKRYS · Health Care | 6.5 | CZK 208.8B | CZK 7,046.04 | 0.35% up | 54% up | ||
| 53 | Vertex PharmaceuticalsVRTX · Health Care | 6.4 | CZK 2.97T | CZK 11,725.07 | 1.84% down | 27% up | ||
| 54 | Kymera TherapeuticsKYMR · Health Care | 6.3 | CZK 227.4B | CZK 2,663.95 | 1.23% down | 87% up | ||
| 55 | IQVIA HoldingsIQV · Health Care | 6.3 | CZK 935.1B | CZK 5,674.15 | 1.17% down | 19% up | ||
| 56 | BrightSpring Health ServicesBTSG · Health Care | 6.2 | CZK 286.8B | CZK 1,441.36 | 5.28% down | 109% up | ||
| 57 | HaemoneticsHAE · Health Care | 6.1 | CZK 121.7B | CZK 2,672.74 | 2.30% down | 64% up | ||
| 58 | Ligand PharmaceuticalsLGND · Health Care | 6.0 | CZK 129.4B | CZK 6,469.32 | 2.74% down | 50% up | ||
| 59 | InsuletPODD · Health Care | 6.0 | CZK 211.7B | CZK 3,051.07 | 2.11% down | 55% down | ||
| 60 | ResMedRMD · Health Care | 5.6 | CZK 741.6B | CZK 5,272.56 | 2.40% down | 1% down | ||
| 61 | Oruka TherapeuticsORKA · Health Care | 5.6 | CZK 149.2B | CZK 2,200.34 | 3.21% up | 255% up | ||
| 62 | Alnylam PharmaceuticalsALNY · Health Care | 5.5 | CZK 445B | CZK 3,322.50 | 0.13% down | 66% down | ||
| 63 | Edwards LifesciencesEW · Health Care | 5.5 | CZK 1.34T | CZK 2,324.71 | 0.79% down | 25% up | ||
| 64 | PACS GroupPACS · Health Care | 5.5 | CZK 148.5B | CZK 935.45 | 9.27% down | 77% up | ||
| 65 | ErascaERAS · Health Care | 5.3 | CZK 109.4B | CZK 311.63 | 1.71% up | 395% up | ||
| 66 | Bio-TechneTECH · Health Care | 5.3 | CZK 254.3B | CZK 1,619.08 | 0.05% down | 24% up | ||
| 67 | Bristol-Myers SquibbBMY · Health Care | 5.1 | CZK 2.66T | CZK 1,303.42 | 1.72% down | 30% up | ||
| 68 | StrykerSYK · Health Care | 5.1 | CZK 2.66T | CZK 6,983.69 | 1.42% down | 12% down | ||
| 69 | Charles River Laboratories InternationalCRL · Health Care | 5.0 | CZK 357.2B | CZK 7,454.42 | 0.46% up | 106% up | ||
| 70 | Lantheus HoldingsLNTH · Health Care | 4.9 | CZK 148.6B | CZK 2,272.16 | 0.04% up | 90% up | ||
| 71 | RadNetRDNT · Health Care | 4.9 | CZK 122.7B | CZK 1,557.71 | 2.60% down | 9% down | ||
| 72 | Encompass HealthEHC · Health Care | 4.8 | CZK 286.9B | CZK 2,923.47 | 2.70% down | 20% up | ||
| 73 | MSA SafetyMSA · Health Care | 4.8 | CZK 151.9B | CZK 3,942.87 | 0.21% down | 16% up | ||
| 74 | RepligenRGEN · Health Care | 4.7 | CZK 247.7B | CZK 3,874.73 | 0.78% up | 12% up | ||
| 75 | Thermo Fisher ScientificTMO · Health Care | 4.7 | CZK 5.73T | CZK 15,469.98 | 0.29% up | 21% up | ||
| 76 | Royalty PharmaRPRX · Health Care | 4.4 | CZK 871.3B | CZK 1,515.29 | 0.90% down | 79% up | ||
| 77 | BrukerBRKR · Health Care | 4.3 | CZK 218.7B | CZK 1,431.79 | 1.64% up | 44% up | ||
| 78 | IncyteINCY · Health Care | 4.2 | CZK 529.5B | CZK 2,597.93 | 0.96% down | 16% up | ||
| 79 | Neurocrine BiosciencesNBIX · Health Care | 4.2 | CZK 358.8B | CZK 3,545.18 | 2.24% down | 17% up | ||
| 80 | Definium TherapeuticsDFTX · Health Care | 4.1 | CZK 87.5B | CZK 639.52 | 1.37% down | 168% up | ||
| 81 | Ensign GroupENSG · Health Care | 4.0 | CZK 231.6B | CZK 3,970.37 | 2.55% down | 2% up | ||
| 82 | HealthEquityHQY · Health Care | 4.0 | CZK 177.4B | CZK 2,144.79 | 1.02% down | 3% down | ||
| 83 | Dianthus TherapeuticsDNTH · Health Care | 3.9 | CZK 107.6B | CZK 1,911.43 | 2.21% up | 108% up | ||
| 84 | Tenet HealthcareTHC · Health Care | 3.8 | CZK 465.3B | CZK 5,846.50 | 3.24% down | 45% up | ||
| 85 | United TherapeuticsUTHR · Health Care | 3.8 | CZK 538B | CZK 12,632.68 | 1.74% down | 22% up | ||
| 86 | Quest DiagnosticsDGX · Health Care | 3.7 | CZK 635.2B | CZK 5,773.58 | 0.16% down | 38% up | ||
| 87 | Oscar HealthOSCR · Health Care | 3.7 | CZK 183.2B | CZK 589.77 | 3.93% down | 112% up | ||
| 88 | VaxcytePCVX · Health Care | 3.6 | CZK 210.5B | CZK 1,330.03 | 2.07% up | 23% up | ||
| 89 | Option Care HealthOPCH · Health Care | 3.6 | CZK 105.4B | CZK 703.87 | 0.32% down | 12% up | ||
| 90 | Abbott LaboratoriesABT · Health Care | 3.6 | CZK 4.04T | CZK 2,331.83 | 0.23% up | 16% down | ||
| 91 | LifeStance Health GroupLFST · Health Care | 3.4 | CZK 112.6B | CZK 296.27 | 3.38% down | 123% up | ||
| 92 | Labcorp HoldingsLH · Health Care | 3.4 | CZK 667B | CZK 8,214.63 | 0.50% down | 42% up | ||
| 93 | GE HealthCare TechnologiesGEHC · Health Care | 3.2 | CZK 826.8B | CZK 1,828.59 | 1.84% down | 12% up | ||
| 94 | SolventumSOLV · Health Care | 3.0 | CZK 320.7B | CZK 1,887.15 | 2.00% down | 9% up | ||
| 95 | DanaherDHR · Health Care | 3.0 | CZK 3.57T | CZK 5,073.38 | 0.32% down | 3% up | ||
| 96 | UnitedHealth GroupUNH · Health Care | 3.0 | CZK 6.51T | CZK 7,270.03 | 6.69% down | 12% up | ||
| 97 | WatersWAT · Health Care | 3.0 | CZK 2.02T | CZK 10,283.26 | 0.92% down | 23% up | ||
| 98 | Henry ScheinHSIC · Health Care | 2.9 | CZK 206.2B | CZK 1,865.55 | 2.23% down | 20% up | ||
| 99 | Merit Medical SystemsMMSI · Health Care | 2.9 | CZK 112.6B | CZK 1,880.03 | 1.75% down | 1% up | ||
| 100 | Regeneron PharmaceuticalsREGN · Health Care | 2.8 | CZK 2.17T | CZK 20,955.98 | 0.47% down | 28% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2673 CZK). 42 companies have no P/B ratio on file and are not ranked here.
Questions and answers
Which health care companies rank first by P/B ratio?
Kodiak Sciences (497), Mettler-Toledo International (440) and Travere Therapeutics (208) are the top three of the 128 health care companies ranked by P/B ratio as of 19 Nov 2026, 17:00 UTC.
How many health care companies are in this ranking?
128 are ranked by P/B ratio. 42 more have no P/B ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 128 health care companies ranked by P/B ratio have a combined market value of CZK 199.38T as of 19 Nov 2026, 17:00 UTC.
What does ranking by P/B ratio measure?
Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Piotroski F-score: the nine tests and what they show
The Piotroski F-score is a 0–9 count of simple accounting tests a company passes: four on profitability, three on debt, liquidity and share issuance, two on operating efficiency. Joseph Piotroski's 2000 paper found that among cheap, high book-to-market stocks, high scorers went on to beat low scorers. It is a screen of financial health, not a valuation.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/B ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=pb-ratio
Underlying data: Yahoo Finance; SEC EDGAR.